CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...

A review found that CD4/CD8 ratio could be used as a prognostic marker for mortality in patients with HIV, though future studies need to be done to confirm these findings. Clinical practices can ...

National Institutes of Health researchers shared new details about idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...

Researchers found that CD4+ T cells can be classified into 18 categories and 12 distinct gene programs, and that characteristic changes in CD4+ T cell profiles are associated with autoimmune disease, ...

Checking CD4 helper T cell levels up to 4 times a year has been a mainstay of HIV/AIDS monitoring, but the value of the test has diminished as the ability to directly detect viral RNA has improved and ...

In a recent study published in Nature Aging, researchers investigated how age-related T-cell defects impacted the effectiveness of messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 ...